nodes	percent_of_prediction	percent_of_DWPC	metapath
Nevirapine—CYP2D6—breast cancer	0.137	0.538	CbGaD
Nevirapine—CYP3A4—breast cancer	0.117	0.462	CbGaD
Nevirapine—CYP2A6—Letrozole—breast cancer	0.069	0.133	CbGbCtD
Nevirapine—CYP2B6—Thiotepa—breast cancer	0.0304	0.0586	CbGbCtD
Nevirapine—CYP1A2—Anastrozole—breast cancer	0.0235	0.0453	CbGbCtD
Nevirapine—CYP1A2—Toremifene—breast cancer	0.0215	0.0414	CbGbCtD
Nevirapine—CYP2C9—Anastrozole—breast cancer	0.0212	0.0408	CbGbCtD
Nevirapine—CYP3A5—Lapatinib—breast cancer	0.0211	0.0406	CbGbCtD
Nevirapine—CYP2A6—Tamoxifen—breast cancer	0.0206	0.0397	CbGbCtD
Nevirapine—CYP2B6—Raloxifene—breast cancer	0.0203	0.0391	CbGbCtD
Nevirapine—CYP3A4—Exemestane—breast cancer	0.0162	0.0313	CbGbCtD
Nevirapine—CYP2C9—Idarubicin—breast cancer	0.016	0.0309	CbGbCtD
Nevirapine—CYP2A6—Fluorouracil—breast cancer	0.0151	0.0292	CbGbCtD
Nevirapine—CYP2D6—Idarubicin—breast cancer	0.0147	0.0283	CbGbCtD
Nevirapine—CYP3A4—Letrozole—breast cancer	0.0138	0.0266	CbGbCtD
Nevirapine—CYP2B6—Tamoxifen—breast cancer	0.0134	0.0258	CbGbCtD
Nevirapine—CYP3A4—Anastrozole—breast cancer	0.0123	0.0237	CbGbCtD
Nevirapine—CYP3A4—Toremifene—breast cancer	0.0113	0.0217	CbGbCtD
Nevirapine—CYP3A5—Tamoxifen—breast cancer	0.0105	0.0203	CbGbCtD
Nevirapine—CYP3A4—Fulvestrant—breast cancer	0.0105	0.0202	CbGbCtD
Nevirapine—CYP2B6—Irinotecan—breast cancer	0.0103	0.0198	CbGbCtD
Nevirapine—CYP3A4—Thiotepa—breast cancer	0.00932	0.018	CbGbCtD
Nevirapine—CYP2C9—Capecitabine—breast cancer	0.00879	0.0169	CbGbCtD
Nevirapine—CYP3A4—Ixabepilone—breast cancer	0.00853	0.0165	CbGbCtD
Nevirapine—CYP3A4—Lapatinib—breast cancer	0.00821	0.0158	CbGbCtD
Nevirapine—CYP3A5—Paclitaxel—breast cancer	0.0082	0.0158	CbGbCtD
Nevirapine—CYP3A5—Irinotecan—breast cancer	0.00809	0.0156	CbGbCtD
Nevirapine—CYP1A2—Tamoxifen—breast cancer	0.00785	0.0151	CbGbCtD
Nevirapine—CYP2D6—Vinorelbine—breast cancer	0.00716	0.0138	CbGbCtD
Nevirapine—CYP2C9—Tamoxifen—breast cancer	0.00707	0.0136	CbGbCtD
Nevirapine—CYP2D6—Tamoxifen—breast cancer	0.00646	0.0125	CbGbCtD
Nevirapine—CYP3A4—Raloxifene—breast cancer	0.00622	0.012	CbGbCtD
Nevirapine—CYP3A5—Docetaxel—breast cancer	0.00593	0.0114	CbGbCtD
Nevirapine—CYP1A2—Fluorouracil—breast cancer	0.00578	0.0112	CbGbCtD
Nevirapine—CYP2B6—Doxorubicin—breast cancer	0.00561	0.0108	CbGbCtD
Nevirapine—CYP2C9—Paclitaxel—breast cancer	0.0055	0.0106	CbGbCtD
Nevirapine—CYP2C9—Fluorouracil—breast cancer	0.00521	0.01	CbGbCtD
Nevirapine—CYP3A4—Vinorelbine—breast cancer	0.00455	0.00878	CbGbCtD
Nevirapine—CYP2D6—Vinblastine—breast cancer	0.00441	0.00851	CbGbCtD
Nevirapine—CYP3A4—Tamoxifen—breast cancer	0.00411	0.00793	CbGbCtD
Nevirapine—CYP3A4—Mitoxantrone—breast cancer	0.00401	0.00773	CbGbCtD
Nevirapine—CYP3A4—Paclitaxel—breast cancer	0.0032	0.00617	CbGbCtD
Nevirapine—CYP3A4—Irinotecan—breast cancer	0.00316	0.00609	CbGbCtD
Nevirapine—CYP3A4—Vinblastine—breast cancer	0.00281	0.00541	CbGbCtD
Nevirapine—CYP2D6—Doxorubicin—breast cancer	0.00271	0.00523	CbGbCtD
Nevirapine—CYP3A4—Docetaxel—breast cancer	0.00231	0.00446	CbGbCtD
Nevirapine—CYP3A4—Doxorubicin—breast cancer	0.00172	0.00333	CbGbCtD
Nevirapine—Malaise—Capecitabine—breast cancer	5.55e-05	0.000347	CcSEcCtD
Nevirapine—Hepatobiliary disease—Methotrexate—breast cancer	5.54e-05	0.000347	CcSEcCtD
Nevirapine—Hypersensitivity—Mitoxantrone—breast cancer	5.52e-05	0.000346	CcSEcCtD
Nevirapine—Hypersensitivity—Irinotecan—breast cancer	5.52e-05	0.000346	CcSEcCtD
Nevirapine—Vomiting—Thiotepa—breast cancer	5.52e-05	0.000346	CcSEcCtD
Nevirapine—Paraesthesia—Paclitaxel—breast cancer	5.49e-05	0.000344	CcSEcCtD
Nevirapine—Rash—Thiotepa—breast cancer	5.47e-05	0.000343	CcSEcCtD
Nevirapine—Dermatitis—Thiotepa—breast cancer	5.47e-05	0.000343	CcSEcCtD
Nevirapine—Agranulocytosis—Methotrexate—breast cancer	5.47e-05	0.000342	CcSEcCtD
Nevirapine—Headache—Thiotepa—breast cancer	5.44e-05	0.000341	CcSEcCtD
Nevirapine—Somnolence—Paclitaxel—breast cancer	5.44e-05	0.000341	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Epirubicin—breast cancer	5.43e-05	0.00034	CcSEcCtD
Nevirapine—Myalgia—Docetaxel—breast cancer	5.41e-05	0.000339	CcSEcCtD
Nevirapine—Arthralgia—Docetaxel—breast cancer	5.41e-05	0.000339	CcSEcCtD
Nevirapine—Nausea—Vinorelbine—breast cancer	5.4e-05	0.000338	CcSEcCtD
Nevirapine—Renal failure—Epirubicin—breast cancer	5.39e-05	0.000338	CcSEcCtD
Nevirapine—Asthenia—Mitoxantrone—breast cancer	5.38e-05	0.000337	CcSEcCtD
Nevirapine—Asthenia—Irinotecan—breast cancer	5.38e-05	0.000337	CcSEcCtD
Nevirapine—Neuropathy peripheral—Epirubicin—breast cancer	5.37e-05	0.000337	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	5.37e-05	0.000336	CcSEcCtD
Nevirapine—Jaundice—Epirubicin—breast cancer	5.34e-05	0.000335	CcSEcCtD
Nevirapine—Conjunctivitis—Epirubicin—breast cancer	5.33e-05	0.000334	CcSEcCtD
Nevirapine—Neutropenia—Doxorubicin—breast cancer	5.32e-05	0.000333	CcSEcCtD
Nevirapine—Decreased appetite—Paclitaxel—breast cancer	5.32e-05	0.000333	CcSEcCtD
Nevirapine—Hypersensitivity—Fluorouracil—breast cancer	5.29e-05	0.000331	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Paclitaxel—breast cancer	5.28e-05	0.000331	CcSEcCtD
Nevirapine—Fatigue—Paclitaxel—breast cancer	5.27e-05	0.00033	CcSEcCtD
Nevirapine—Hepatitis—Methotrexate—breast cancer	5.26e-05	0.000329	CcSEcCtD
Nevirapine—Asthenia—Gemcitabine—breast cancer	5.24e-05	0.000328	CcSEcCtD
Nevirapine—Arthralgia—Capecitabine—breast cancer	5.24e-05	0.000328	CcSEcCtD
Nevirapine—Myalgia—Capecitabine—breast cancer	5.24e-05	0.000328	CcSEcCtD
Nevirapine—Pain—Paclitaxel—breast cancer	5.23e-05	0.000328	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	5.2e-05	0.000326	CcSEcCtD
Nevirapine—Hepatobiliary disease—Epirubicin—breast cancer	5.18e-05	0.000325	CcSEcCtD
Nevirapine—Oedema—Docetaxel—breast cancer	5.18e-05	0.000325	CcSEcCtD
Nevirapine—Anaphylactic shock—Docetaxel—breast cancer	5.18e-05	0.000325	CcSEcCtD
Nevirapine—Discomfort—Capecitabine—breast cancer	5.17e-05	0.000324	CcSEcCtD
Nevirapine—Pruritus—Gemcitabine—breast cancer	5.17e-05	0.000324	CcSEcCtD
Nevirapine—Nausea—Thiotepa—breast cancer	5.16e-05	0.000323	CcSEcCtD
Nevirapine—Hyperglycaemia—Doxorubicin—breast cancer	5.13e-05	0.000321	CcSEcCtD
Nevirapine—Diarrhoea—Irinotecan—breast cancer	5.13e-05	0.000321	CcSEcCtD
Nevirapine—Diarrhoea—Mitoxantrone—breast cancer	5.13e-05	0.000321	CcSEcCtD
Nevirapine—Agranulocytosis—Epirubicin—breast cancer	5.12e-05	0.00032	CcSEcCtD
Nevirapine—Nervous system disorder—Docetaxel—breast cancer	5.08e-05	0.000318	CcSEcCtD
Nevirapine—Pruritus—Fluorouracil—breast cancer	5.08e-05	0.000318	CcSEcCtD
Nevirapine—Thrombocytopenia—Docetaxel—breast cancer	5.08e-05	0.000318	CcSEcCtD
Nevirapine—Feeling abnormal—Paclitaxel—breast cancer	5.04e-05	0.000316	CcSEcCtD
Nevirapine—Skin disorder—Docetaxel—breast cancer	5.04e-05	0.000315	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Doxorubicin—breast cancer	5.03e-05	0.000315	CcSEcCtD
Nevirapine—Oedema—Capecitabine—breast cancer	5.02e-05	0.000314	CcSEcCtD
Nevirapine—Gastrointestinal pain—Paclitaxel—breast cancer	5e-05	0.000313	CcSEcCtD
Nevirapine—Diarrhoea—Gemcitabine—breast cancer	5e-05	0.000313	CcSEcCtD
Nevirapine—Renal failure—Doxorubicin—breast cancer	4.99e-05	0.000312	CcSEcCtD
Nevirapine—Erythema multiforme—Methotrexate—breast cancer	4.97e-05	0.000311	CcSEcCtD
Nevirapine—Neuropathy peripheral—Doxorubicin—breast cancer	4.97e-05	0.000311	CcSEcCtD
Nevirapine—Jaundice—Doxorubicin—breast cancer	4.94e-05	0.00031	CcSEcCtD
Nevirapine—Anorexia—Docetaxel—breast cancer	4.94e-05	0.000309	CcSEcCtD
Nevirapine—Conjunctivitis—Doxorubicin—breast cancer	4.93e-05	0.000309	CcSEcCtD
Nevirapine—Nervous system disorder—Capecitabine—breast cancer	4.92e-05	0.000308	CcSEcCtD
Nevirapine—Hepatitis—Epirubicin—breast cancer	4.92e-05	0.000308	CcSEcCtD
Nevirapine—Diarrhoea—Fluorouracil—breast cancer	4.91e-05	0.000308	CcSEcCtD
Nevirapine—Thrombocytopenia—Capecitabine—breast cancer	4.91e-05	0.000308	CcSEcCtD
Nevirapine—Skin disorder—Capecitabine—breast cancer	4.87e-05	0.000305	CcSEcCtD
Nevirapine—Urticaria—Paclitaxel—breast cancer	4.86e-05	0.000304	CcSEcCtD
Nevirapine—Connective tissue disorder—Epirubicin—breast cancer	4.84e-05	0.000303	CcSEcCtD
Nevirapine—Abdominal pain—Paclitaxel—breast cancer	4.83e-05	0.000303	CcSEcCtD
Nevirapine—Body temperature increased—Paclitaxel—breast cancer	4.83e-05	0.000303	CcSEcCtD
Nevirapine—Hepatobiliary disease—Doxorubicin—breast cancer	4.8e-05	0.0003	CcSEcCtD
Nevirapine—Anorexia—Capecitabine—breast cancer	4.78e-05	0.0003	CcSEcCtD
Nevirapine—Vomiting—Irinotecan—breast cancer	4.77e-05	0.000299	CcSEcCtD
Nevirapine—Vomiting—Mitoxantrone—breast cancer	4.77e-05	0.000299	CcSEcCtD
Nevirapine—Immune system disorder—Methotrexate—breast cancer	4.75e-05	0.000298	CcSEcCtD
Nevirapine—Agranulocytosis—Doxorubicin—breast cancer	4.73e-05	0.000296	CcSEcCtD
Nevirapine—Rash—Irinotecan—breast cancer	4.73e-05	0.000296	CcSEcCtD
Nevirapine—Rash—Mitoxantrone—breast cancer	4.73e-05	0.000296	CcSEcCtD
Nevirapine—Dermatitis—Mitoxantrone—breast cancer	4.72e-05	0.000296	CcSEcCtD
Nevirapine—Dermatitis—Irinotecan—breast cancer	4.72e-05	0.000296	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Docetaxel—breast cancer	4.72e-05	0.000296	CcSEcCtD
Nevirapine—Headache—Irinotecan—breast cancer	4.7e-05	0.000294	CcSEcCtD
Nevirapine—Headache—Mitoxantrone—breast cancer	4.7e-05	0.000294	CcSEcCtD
Nevirapine—Paraesthesia—Docetaxel—breast cancer	4.65e-05	0.000292	CcSEcCtD
Nevirapine—Erythema multiforme—Epirubicin—breast cancer	4.65e-05	0.000291	CcSEcCtD
Nevirapine—Vomiting—Gemcitabine—breast cancer	4.64e-05	0.000291	CcSEcCtD
Nevirapine—Somnolence—Docetaxel—breast cancer	4.61e-05	0.000289	CcSEcCtD
Nevirapine—Rash—Gemcitabine—breast cancer	4.61e-05	0.000288	CcSEcCtD
Nevirapine—Dermatitis—Gemcitabine—breast cancer	4.6e-05	0.000288	CcSEcCtD
Nevirapine—Erythema—Methotrexate—breast cancer	4.58e-05	0.000287	CcSEcCtD
Nevirapine—Headache—Gemcitabine—breast cancer	4.58e-05	0.000287	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Capecitabine—breast cancer	4.57e-05	0.000286	CcSEcCtD
Nevirapine—Vomiting—Fluorouracil—breast cancer	4.57e-05	0.000286	CcSEcCtD
Nevirapine—Hepatitis—Doxorubicin—breast cancer	4.55e-05	0.000285	CcSEcCtD
Nevirapine—Rash—Fluorouracil—breast cancer	4.53e-05	0.000284	CcSEcCtD
Nevirapine—Dermatitis—Fluorouracil—breast cancer	4.52e-05	0.000283	CcSEcCtD
Nevirapine—Paraesthesia—Capecitabine—breast cancer	4.51e-05	0.000282	CcSEcCtD
Nevirapine—Decreased appetite—Docetaxel—breast cancer	4.51e-05	0.000282	CcSEcCtD
Nevirapine—Hypersensitivity—Paclitaxel—breast cancer	4.51e-05	0.000282	CcSEcCtD
Nevirapine—Headache—Fluorouracil—breast cancer	4.5e-05	0.000282	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Docetaxel—breast cancer	4.48e-05	0.00028	CcSEcCtD
Nevirapine—Connective tissue disorder—Doxorubicin—breast cancer	4.47e-05	0.00028	CcSEcCtD
Nevirapine—Fatigue—Docetaxel—breast cancer	4.47e-05	0.00028	CcSEcCtD
Nevirapine—Nausea—Irinotecan—breast cancer	4.45e-05	0.000279	CcSEcCtD
Nevirapine—Nausea—Mitoxantrone—breast cancer	4.45e-05	0.000279	CcSEcCtD
Nevirapine—Immune system disorder—Epirubicin—breast cancer	4.45e-05	0.000278	CcSEcCtD
Nevirapine—Pain—Docetaxel—breast cancer	4.43e-05	0.000278	CcSEcCtD
Nevirapine—Asthenia—Paclitaxel—breast cancer	4.39e-05	0.000275	CcSEcCtD
Nevirapine—Decreased appetite—Capecitabine—breast cancer	4.36e-05	0.000273	CcSEcCtD
Nevirapine—Nausea—Gemcitabine—breast cancer	4.34e-05	0.000272	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Capecitabine—breast cancer	4.33e-05	0.000271	CcSEcCtD
Nevirapine—Fatigue—Capecitabine—breast cancer	4.33e-05	0.000271	CcSEcCtD
Nevirapine—Pruritus—Paclitaxel—breast cancer	4.33e-05	0.000271	CcSEcCtD
Nevirapine—Erythema multiforme—Doxorubicin—breast cancer	4.31e-05	0.00027	CcSEcCtD
Nevirapine—Pain—Capecitabine—breast cancer	4.29e-05	0.000269	CcSEcCtD
Nevirapine—Erythema—Epirubicin—breast cancer	4.28e-05	0.000268	CcSEcCtD
Nevirapine—Feeling abnormal—Docetaxel—breast cancer	4.27e-05	0.000268	CcSEcCtD
Nevirapine—Nausea—Fluorouracil—breast cancer	4.27e-05	0.000267	CcSEcCtD
Nevirapine—Ill-defined disorder—Methotrexate—breast cancer	4.25e-05	0.000266	CcSEcCtD
Nevirapine—Gastrointestinal pain—Docetaxel—breast cancer	4.24e-05	0.000265	CcSEcCtD
Nevirapine—Anaemia—Methotrexate—breast cancer	4.23e-05	0.000265	CcSEcCtD
Nevirapine—Diarrhoea—Paclitaxel—breast cancer	4.18e-05	0.000262	CcSEcCtD
Nevirapine—Feeling abnormal—Capecitabine—breast cancer	4.14e-05	0.000259	CcSEcCtD
Nevirapine—Malaise—Methotrexate—breast cancer	4.13e-05	0.000259	CcSEcCtD
Nevirapine—Immune system disorder—Doxorubicin—breast cancer	4.11e-05	0.000258	CcSEcCtD
Nevirapine—Gastrointestinal pain—Capecitabine—breast cancer	4.1e-05	0.000257	CcSEcCtD
Nevirapine—Abdominal pain—Docetaxel—breast cancer	4.1e-05	0.000257	CcSEcCtD
Nevirapine—Body temperature increased—Docetaxel—breast cancer	4.1e-05	0.000257	CcSEcCtD
Nevirapine—Urticaria—Capecitabine—breast cancer	3.99e-05	0.00025	CcSEcCtD
Nevirapine—Ill-defined disorder—Epirubicin—breast cancer	3.97e-05	0.000249	CcSEcCtD
Nevirapine—Abdominal pain—Capecitabine—breast cancer	3.97e-05	0.000248	CcSEcCtD
Nevirapine—Body temperature increased—Capecitabine—breast cancer	3.97e-05	0.000248	CcSEcCtD
Nevirapine—Erythema—Doxorubicin—breast cancer	3.96e-05	0.000248	CcSEcCtD
Nevirapine—Anaemia—Epirubicin—breast cancer	3.96e-05	0.000248	CcSEcCtD
Nevirapine—Myalgia—Methotrexate—breast cancer	3.9e-05	0.000244	CcSEcCtD
Nevirapine—Arthralgia—Methotrexate—breast cancer	3.9e-05	0.000244	CcSEcCtD
Nevirapine—Vomiting—Paclitaxel—breast cancer	3.89e-05	0.000244	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.87e-05	0.000242	CcSEcCtD
Nevirapine—Malaise—Epirubicin—breast cancer	3.86e-05	0.000242	CcSEcCtD
Nevirapine—Rash—Paclitaxel—breast cancer	3.86e-05	0.000242	CcSEcCtD
Nevirapine—Dermatitis—Paclitaxel—breast cancer	3.85e-05	0.000241	CcSEcCtD
Nevirapine—Discomfort—Methotrexate—breast cancer	3.85e-05	0.000241	CcSEcCtD
Nevirapine—Headache—Paclitaxel—breast cancer	3.83e-05	0.00024	CcSEcCtD
Nevirapine—Hypersensitivity—Docetaxel—breast cancer	3.82e-05	0.000239	CcSEcCtD
Nevirapine—Anaphylactic shock—Methotrexate—breast cancer	3.74e-05	0.000234	CcSEcCtD
Nevirapine—Asthenia—Docetaxel—breast cancer	3.72e-05	0.000233	CcSEcCtD
Nevirapine—Hypersensitivity—Capecitabine—breast cancer	3.7e-05	0.000232	CcSEcCtD
Nevirapine—Ill-defined disorder—Doxorubicin—breast cancer	3.68e-05	0.00023	CcSEcCtD
Nevirapine—Pruritus—Docetaxel—breast cancer	3.67e-05	0.00023	CcSEcCtD
Nevirapine—Nervous system disorder—Methotrexate—breast cancer	3.66e-05	0.000229	CcSEcCtD
Nevirapine—Anaemia—Doxorubicin—breast cancer	3.66e-05	0.000229	CcSEcCtD
Nevirapine—Thrombocytopenia—Methotrexate—breast cancer	3.66e-05	0.000229	CcSEcCtD
Nevirapine—Myalgia—Epirubicin—breast cancer	3.65e-05	0.000228	CcSEcCtD
Nevirapine—Arthralgia—Epirubicin—breast cancer	3.65e-05	0.000228	CcSEcCtD
Nevirapine—Nausea—Paclitaxel—breast cancer	3.63e-05	0.000228	CcSEcCtD
Nevirapine—Skin disorder—Methotrexate—breast cancer	3.63e-05	0.000227	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.62e-05	0.000227	CcSEcCtD
Nevirapine—Discomfort—Epirubicin—breast cancer	3.6e-05	0.000226	CcSEcCtD
Nevirapine—Asthenia—Capecitabine—breast cancer	3.6e-05	0.000226	CcSEcCtD
Nevirapine—Malaise—Doxorubicin—breast cancer	3.57e-05	0.000224	CcSEcCtD
Nevirapine—Anorexia—Methotrexate—breast cancer	3.56e-05	0.000223	CcSEcCtD
Nevirapine—Pruritus—Capecitabine—breast cancer	3.55e-05	0.000222	CcSEcCtD
Nevirapine—Diarrhoea—Docetaxel—breast cancer	3.55e-05	0.000222	CcSEcCtD
Nevirapine—Anaphylactic shock—Epirubicin—breast cancer	3.5e-05	0.000219	CcSEcCtD
Nevirapine—Oedema—Epirubicin—breast cancer	3.5e-05	0.000219	CcSEcCtD
Nevirapine—Diarrhoea—Capecitabine—breast cancer	3.43e-05	0.000215	CcSEcCtD
Nevirapine—Nervous system disorder—Epirubicin—breast cancer	3.43e-05	0.000215	CcSEcCtD
Nevirapine—Thrombocytopenia—Epirubicin—breast cancer	3.42e-05	0.000214	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Methotrexate—breast cancer	3.4e-05	0.000213	CcSEcCtD
Nevirapine—Skin disorder—Epirubicin—breast cancer	3.4e-05	0.000213	CcSEcCtD
Nevirapine—Myalgia—Doxorubicin—breast cancer	3.37e-05	0.000211	CcSEcCtD
Nevirapine—Arthralgia—Doxorubicin—breast cancer	3.37e-05	0.000211	CcSEcCtD
Nevirapine—Paraesthesia—Methotrexate—breast cancer	3.35e-05	0.00021	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.35e-05	0.00021	CcSEcCtD
Nevirapine—Discomfort—Doxorubicin—breast cancer	3.33e-05	0.000209	CcSEcCtD
Nevirapine—Anorexia—Epirubicin—breast cancer	3.33e-05	0.000209	CcSEcCtD
Nevirapine—Somnolence—Methotrexate—breast cancer	3.32e-05	0.000208	CcSEcCtD
Nevirapine—Vomiting—Docetaxel—breast cancer	3.3e-05	0.000206	CcSEcCtD
Nevirapine—Rash—Docetaxel—breast cancer	3.27e-05	0.000205	CcSEcCtD
Nevirapine—Dermatitis—Docetaxel—breast cancer	3.27e-05	0.000205	CcSEcCtD
Nevirapine—Decreased appetite—Methotrexate—breast cancer	3.25e-05	0.000203	CcSEcCtD
Nevirapine—Headache—Docetaxel—breast cancer	3.25e-05	0.000203	CcSEcCtD
Nevirapine—Oedema—Doxorubicin—breast cancer	3.24e-05	0.000203	CcSEcCtD
Nevirapine—Anaphylactic shock—Doxorubicin—breast cancer	3.24e-05	0.000203	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Methotrexate—breast cancer	3.23e-05	0.000202	CcSEcCtD
Nevirapine—Fatigue—Methotrexate—breast cancer	3.22e-05	0.000202	CcSEcCtD
Nevirapine—Pain—Methotrexate—breast cancer	3.19e-05	0.0002	CcSEcCtD
Nevirapine—Vomiting—Capecitabine—breast cancer	3.19e-05	0.0002	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Epirubicin—breast cancer	3.19e-05	0.0002	CcSEcCtD
Nevirapine—Nervous system disorder—Doxorubicin—breast cancer	3.17e-05	0.000199	CcSEcCtD
Nevirapine—Thrombocytopenia—Doxorubicin—breast cancer	3.17e-05	0.000198	CcSEcCtD
Nevirapine—Rash—Capecitabine—breast cancer	3.16e-05	0.000198	CcSEcCtD
Nevirapine—Dermatitis—Capecitabine—breast cancer	3.16e-05	0.000198	CcSEcCtD
Nevirapine—Headache—Capecitabine—breast cancer	3.14e-05	0.000197	CcSEcCtD
Nevirapine—Skin disorder—Doxorubicin—breast cancer	3.14e-05	0.000197	CcSEcCtD
Nevirapine—Paraesthesia—Epirubicin—breast cancer	3.14e-05	0.000197	CcSEcCtD
Nevirapine—Somnolence—Epirubicin—breast cancer	3.11e-05	0.000195	CcSEcCtD
Nevirapine—Anorexia—Doxorubicin—breast cancer	3.08e-05	0.000193	CcSEcCtD
Nevirapine—Nausea—Docetaxel—breast cancer	3.08e-05	0.000193	CcSEcCtD
Nevirapine—Feeling abnormal—Methotrexate—breast cancer	3.08e-05	0.000193	CcSEcCtD
Nevirapine—Gastrointestinal pain—Methotrexate—breast cancer	3.06e-05	0.000191	CcSEcCtD
Nevirapine—Decreased appetite—Epirubicin—breast cancer	3.04e-05	0.00019	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Epirubicin—breast cancer	3.02e-05	0.000189	CcSEcCtD
Nevirapine—Fatigue—Epirubicin—breast cancer	3.01e-05	0.000189	CcSEcCtD
Nevirapine—Pain—Epirubicin—breast cancer	2.99e-05	0.000187	CcSEcCtD
Nevirapine—Nausea—Capecitabine—breast cancer	2.98e-05	0.000187	CcSEcCtD
Nevirapine—Urticaria—Methotrexate—breast cancer	2.97e-05	0.000186	CcSEcCtD
Nevirapine—Body temperature increased—Methotrexate—breast cancer	2.95e-05	0.000185	CcSEcCtD
Nevirapine—Abdominal pain—Methotrexate—breast cancer	2.95e-05	0.000185	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.95e-05	0.000185	CcSEcCtD
Nevirapine—Paraesthesia—Doxorubicin—breast cancer	2.9e-05	0.000182	CcSEcCtD
Nevirapine—Feeling abnormal—Epirubicin—breast cancer	2.88e-05	0.00018	CcSEcCtD
Nevirapine—Somnolence—Doxorubicin—breast cancer	2.88e-05	0.00018	CcSEcCtD
Nevirapine—Gastrointestinal pain—Epirubicin—breast cancer	2.86e-05	0.000179	CcSEcCtD
Nevirapine—Decreased appetite—Doxorubicin—breast cancer	2.81e-05	0.000176	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Doxorubicin—breast cancer	2.79e-05	0.000175	CcSEcCtD
Nevirapine—Fatigue—Doxorubicin—breast cancer	2.79e-05	0.000175	CcSEcCtD
Nevirapine—Urticaria—Epirubicin—breast cancer	2.78e-05	0.000174	CcSEcCtD
Nevirapine—Pain—Doxorubicin—breast cancer	2.77e-05	0.000173	CcSEcCtD
Nevirapine—Abdominal pain—Epirubicin—breast cancer	2.76e-05	0.000173	CcSEcCtD
Nevirapine—Body temperature increased—Epirubicin—breast cancer	2.76e-05	0.000173	CcSEcCtD
Nevirapine—Hypersensitivity—Methotrexate—breast cancer	2.75e-05	0.000172	CcSEcCtD
Nevirapine—Asthenia—Methotrexate—breast cancer	2.68e-05	0.000168	CcSEcCtD
Nevirapine—Feeling abnormal—Doxorubicin—breast cancer	2.67e-05	0.000167	CcSEcCtD
Nevirapine—Gastrointestinal pain—Doxorubicin—breast cancer	2.65e-05	0.000166	CcSEcCtD
Nevirapine—Pruritus—Methotrexate—breast cancer	2.64e-05	0.000166	CcSEcCtD
Nevirapine—Hypersensitivity—Epirubicin—breast cancer	2.58e-05	0.000161	CcSEcCtD
Nevirapine—Urticaria—Doxorubicin—breast cancer	2.57e-05	0.000161	CcSEcCtD
Nevirapine—Abdominal pain—Doxorubicin—breast cancer	2.56e-05	0.00016	CcSEcCtD
Nevirapine—Body temperature increased—Doxorubicin—breast cancer	2.56e-05	0.00016	CcSEcCtD
Nevirapine—Diarrhoea—Methotrexate—breast cancer	2.56e-05	0.00016	CcSEcCtD
Nevirapine—Asthenia—Epirubicin—breast cancer	2.51e-05	0.000157	CcSEcCtD
Nevirapine—Pruritus—Epirubicin—breast cancer	2.47e-05	0.000155	CcSEcCtD
Nevirapine—Diarrhoea—Epirubicin—breast cancer	2.39e-05	0.00015	CcSEcCtD
Nevirapine—Hypersensitivity—Doxorubicin—breast cancer	2.38e-05	0.000149	CcSEcCtD
Nevirapine—Vomiting—Methotrexate—breast cancer	2.38e-05	0.000149	CcSEcCtD
Nevirapine—Rash—Methotrexate—breast cancer	2.36e-05	0.000148	CcSEcCtD
Nevirapine—Dermatitis—Methotrexate—breast cancer	2.35e-05	0.000147	CcSEcCtD
Nevirapine—Headache—Methotrexate—breast cancer	2.34e-05	0.000147	CcSEcCtD
Nevirapine—Asthenia—Doxorubicin—breast cancer	2.32e-05	0.000145	CcSEcCtD
Nevirapine—Pruritus—Doxorubicin—breast cancer	2.29e-05	0.000143	CcSEcCtD
Nevirapine—Vomiting—Epirubicin—breast cancer	2.22e-05	0.000139	CcSEcCtD
Nevirapine—Nausea—Methotrexate—breast cancer	2.22e-05	0.000139	CcSEcCtD
Nevirapine—Diarrhoea—Doxorubicin—breast cancer	2.21e-05	0.000139	CcSEcCtD
Nevirapine—Rash—Epirubicin—breast cancer	2.2e-05	0.000138	CcSEcCtD
Nevirapine—Dermatitis—Epirubicin—breast cancer	2.2e-05	0.000138	CcSEcCtD
Nevirapine—Headache—Epirubicin—breast cancer	2.19e-05	0.000137	CcSEcCtD
Nevirapine—Nausea—Epirubicin—breast cancer	2.08e-05	0.00013	CcSEcCtD
Nevirapine—Vomiting—Doxorubicin—breast cancer	2.06e-05	0.000129	CcSEcCtD
Nevirapine—Rash—Doxorubicin—breast cancer	2.04e-05	0.000128	CcSEcCtD
Nevirapine—Dermatitis—Doxorubicin—breast cancer	2.04e-05	0.000128	CcSEcCtD
Nevirapine—Headache—Doxorubicin—breast cancer	2.03e-05	0.000127	CcSEcCtD
Nevirapine—Nausea—Doxorubicin—breast cancer	1.92e-05	0.00012	CcSEcCtD
Nevirapine—CYP3A4—Metabolism—PPARGC1B—breast cancer	4.94e-06	7.29e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ITPR1—breast cancer	4.94e-06	7.28e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—MED12—breast cancer	4.93e-06	7.27e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—DPYD—breast cancer	4.93e-06	7.27e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP17A1—breast cancer	4.87e-06	7.19e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ABCB1—breast cancer	4.86e-06	7.17e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALDOA—breast cancer	4.85e-06	7.16e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP17A1—breast cancer	4.83e-06	7.13e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTGS1—breast cancer	4.82e-06	7.12e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ENO1—breast cancer	4.82e-06	7.12e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ENO1—breast cancer	4.78e-06	7.05e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTGS1—breast cancer	4.78e-06	7.05e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—TYMS—breast cancer	4.77e-06	7.04e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CAV1—breast cancer	4.77e-06	7.03e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.76e-06	7.03e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ABCB1—breast cancer	4.75e-06	7.01e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PLA2G4A—breast cancer	4.72e-06	6.96e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—NCOR1—breast cancer	4.72e-06	6.96e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTM1—breast cancer	4.72e-06	6.96e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NCOA3—breast cancer	4.71e-06	6.95e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.7e-06	6.94e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP2D6—breast cancer	4.69e-06	6.92e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SLC2A2—breast cancer	4.68e-06	6.9e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CA9—breast cancer	4.67e-06	6.89e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTA4—breast cancer	4.67e-06	6.89e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—TYMS—breast cancer	4.66e-06	6.88e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NCOA2—breast cancer	4.64e-06	6.85e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.63e-06	6.83e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTM1—breast cancer	4.61e-06	6.8e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PLA2G4A—breast cancer	4.61e-06	6.8e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—NCOR1—breast cancer	4.61e-06	6.8e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NCOA2—breast cancer	4.6e-06	6.79e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ABCG2—breast cancer	4.58e-06	6.76e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CPT1A—breast cancer	4.58e-06	6.76e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—MTR—breast cancer	4.58e-06	6.76e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GPX2—breast cancer	4.55e-06	6.71e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTA2—breast cancer	4.55e-06	6.71e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GPX1—breast cancer	4.52e-06	6.66e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—FASN—breast cancer	4.5e-06	6.64e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HPGDS—breast cancer	4.5e-06	6.63e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GPX4—breast cancer	4.49e-06	6.63e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SULT1A1—breast cancer	4.49e-06	6.63e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—BCHE—breast cancer	4.48e-06	6.62e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CYP1A1—breast cancer	4.47e-06	6.6e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HBA1—breast cancer	4.47e-06	6.59e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—FASN—breast cancer	4.46e-06	6.59e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—BCHE—breast cancer	4.45e-06	6.56e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ERCC2—breast cancer	4.44e-06	6.54e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SLC5A5—breast cancer	4.43e-06	6.53e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GPX1—breast cancer	4.42e-06	6.51e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SLC5A5—breast cancer	4.39e-06	6.48e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—IDH1—breast cancer	4.39e-06	6.48e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTA1—breast cancer	4.39e-06	6.48e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CYP1A1—breast cancer	4.37e-06	6.45e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTT1—breast cancer	4.36e-06	6.43e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ACHE—breast cancer	4.36e-06	6.43e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CG—breast cancer	4.34e-06	6.4e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NAT2—breast cancer	4.34e-06	6.4e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ERCC2—breast cancer	4.34e-06	6.4e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NQO1—breast cancer	4.28e-06	6.31e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SLC2A1—breast cancer	4.28e-06	6.31e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SLC2A1—breast cancer	4.24e-06	6.26e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NQO1—breast cancer	4.24e-06	6.26e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP3A4—breast cancer	4.17e-06	6.15e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—MTHFR—breast cancer	4.17e-06	6.15e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.15e-06	6.13e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP3A4—breast cancer	4.14e-06	6.1e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP17A1—breast cancer	4.13e-06	6.09e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.11e-06	6.07e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP1B1—breast cancer	4.1e-06	6.05e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ENO1—breast cancer	4.09e-06	6.03e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTGS1—breast cancer	4.09e-06	6.03e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—MTHFR—breast cancer	4.07e-06	6.01e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.07e-06	6.01e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP1B1—breast cancer	4.07e-06	6e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—HSP90AA1—breast cancer	4.02e-06	5.93e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.02e-06	5.93e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP2D6—breast cancer	4.01e-06	5.91e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—HSP90AA1—breast cancer	3.99e-06	5.88e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NCOA2—breast cancer	3.93e-06	5.8e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NCOA1—breast cancer	3.91e-06	5.77e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NCOA1—breast cancer	3.88e-06	5.72e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—STK11—breast cancer	3.86e-06	5.69e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP19A1—breast cancer	3.86e-06	5.69e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CAV1—breast cancer	3.85e-06	5.67e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—STK11—breast cancer	3.82e-06	5.64e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP19A1—breast cancer	3.82e-06	5.64e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CD—breast cancer	3.82e-06	5.63e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—FASN—breast cancer	3.81e-06	5.63e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—DPYD—breast cancer	3.81e-06	5.61e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—MED12—breast cancer	3.81e-06	5.61e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—BCHE—breast cancer	3.8e-06	5.6e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ALB—breast cancer	3.77e-06	5.56e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CAV1—breast cancer	3.76e-06	5.55e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SLC5A5—breast cancer	3.75e-06	5.54e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALDOA—breast cancer	3.75e-06	5.53e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NCOA3—breast cancer	3.64e-06	5.37e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SLC2A1—breast cancer	3.62e-06	5.35e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NQO1—breast cancer	3.62e-06	5.35e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC2A2—breast cancer	3.61e-06	5.33e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—NOS3—breast cancer	3.6e-06	5.32e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.59e-06	5.29e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—COMT—breast cancer	3.58e-06	5.29e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTP1—breast cancer	3.57e-06	5.26e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—COMT—breast cancer	3.55e-06	5.24e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.55e-06	5.23e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—MTR—breast cancer	3.54e-06	5.22e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CPT1A—breast cancer	3.54e-06	5.22e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ABCG2—breast cancer	3.54e-06	5.22e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTP1—breast cancer	3.54e-06	5.22e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP3A4—breast cancer	3.53e-06	5.21e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—HMOX1—breast cancer	3.52e-06	5.19e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.52e-06	5.19e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ITPR1—breast cancer	3.51e-06	5.18e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CG—breast cancer	3.5e-06	5.17e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—HMOX1—breast cancer	3.49e-06	5.15e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ITPR1—breast cancer	3.48e-06	5.13e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP1B1—breast cancer	3.47e-06	5.13e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HPGDS—breast cancer	3.47e-06	5.12e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HBA1—breast cancer	3.45e-06	5.09e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CG—breast cancer	3.42e-06	5.05e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HSP90AA1—breast cancer	3.41e-06	5.03e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ABCB1—breast cancer	3.38e-06	4.98e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTT1—breast cancer	3.37e-06	4.96e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ACHE—breast cancer	3.37e-06	4.96e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ABCB1—breast cancer	3.35e-06	4.94e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CB—breast cancer	3.33e-06	4.91e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—TYMS—breast cancer	3.32e-06	4.89e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NCOA1—breast cancer	3.31e-06	4.89e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTGS2—breast cancer	3.3e-06	4.86e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—TYMS—breast cancer	3.29e-06	4.85e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PLA2G4A—breast cancer	3.28e-06	4.84e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTM1—breast cancer	3.28e-06	4.84e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NCOR1—breast cancer	3.28e-06	4.84e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP19A1—breast cancer	3.27e-06	4.82e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—STK11—breast cancer	3.27e-06	4.82e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PLA2G4A—breast cancer	3.25e-06	4.8e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTM1—breast cancer	3.25e-06	4.8e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NCOR1—breast cancer	3.25e-06	4.8e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP17A1—breast cancer	3.19e-06	4.7e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ENO1—breast cancer	3.15e-06	4.65e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTGS1—breast cancer	3.15e-06	4.65e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GPX1—breast cancer	3.14e-06	4.63e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GPX1—breast cancer	3.11e-06	4.59e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP1A1—breast cancer	3.11e-06	4.59e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP2D6—breast cancer	3.09e-06	4.56e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ERCC2—breast cancer	3.08e-06	4.55e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP1A1—breast cancer	3.08e-06	4.55e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CD—breast cancer	3.08e-06	4.54e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.07e-06	4.52e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ERCC2—breast cancer	3.06e-06	4.51e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ALB—breast cancer	3.04e-06	4.48e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—COMT—breast cancer	3.04e-06	4.48e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NCOA2—breast cancer	3.04e-06	4.48e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTP1—breast cancer	3.02e-06	4.46e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CD—breast cancer	3.01e-06	4.44e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HMOX1—breast cancer	2.98e-06	4.4e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ITPR1—breast cancer	2.97e-06	4.39e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ALB—breast cancer	2.97e-06	4.38e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—FASN—breast cancer	2.94e-06	4.34e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—BCHE—breast cancer	2.93e-06	4.33e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—NOS3—breast cancer	2.91e-06	4.29e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—MTHFR—breast cancer	2.9e-06	4.27e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC5A5—breast cancer	2.9e-06	4.27e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTEN—breast cancer	2.87e-06	4.24e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—MTHFR—breast cancer	2.87e-06	4.24e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ABCB1—breast cancer	2.86e-06	4.22e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—NOS3—breast cancer	2.84e-06	4.19e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—TYMS—breast cancer	2.81e-06	4.15e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NQO1—breast cancer	2.8e-06	4.13e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC2A1—breast cancer	2.8e-06	4.13e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTM1—breast cancer	2.78e-06	4.1e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NCOR1—breast cancer	2.78e-06	4.1e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PLA2G4A—breast cancer	2.78e-06	4.1e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CB—breast cancer	2.68e-06	3.96e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP1B1—breast cancer	2.68e-06	3.96e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CAV1—breast cancer	2.67e-06	3.94e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GPX1—breast cancer	2.66e-06	3.92e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTGS2—breast cancer	2.66e-06	3.92e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CAV1—breast cancer	2.65e-06	3.91e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP1A1—breast cancer	2.63e-06	3.88e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.63e-06	3.88e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CB—breast cancer	2.62e-06	3.87e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ERCC2—breast cancer	2.61e-06	3.85e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTGS2—breast cancer	2.6e-06	3.83e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NCOA1—breast cancer	2.56e-06	3.77e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.53e-06	3.73e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP19A1—breast cancer	2.52e-06	3.72e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—STK11—breast cancer	2.52e-06	3.72e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—MTHFR—breast cancer	2.45e-06	3.62e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CG—breast cancer	2.43e-06	3.59e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CG—breast cancer	2.41e-06	3.56e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—COMT—breast cancer	2.34e-06	3.46e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTP1—breast cancer	2.33e-06	3.44e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTEN—breast cancer	2.32e-06	3.42e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HMOX1—breast cancer	2.3e-06	3.39e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ITPR1—breast cancer	2.3e-06	3.39e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTEN—breast cancer	2.27e-06	3.34e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CAV1—breast cancer	2.26e-06	3.34e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ABCB1—breast cancer	2.21e-06	3.26e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—TYMS—breast cancer	2.17e-06	3.2e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.16e-06	3.19e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NCOR1—breast cancer	2.14e-06	3.16e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTM1—breast cancer	2.14e-06	3.16e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.14e-06	3.16e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CD—breast cancer	2.14e-06	3.16e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CD—breast cancer	2.12e-06	3.13e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALB—breast cancer	2.11e-06	3.12e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALB—breast cancer	2.09e-06	3.09e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CG—breast cancer	2.06e-06	3.04e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GPX1—breast cancer	2.05e-06	3.03e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP1A1—breast cancer	2.03e-06	3e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CA—breast cancer	2.03e-06	2.99e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NOS3—breast cancer	2.02e-06	2.98e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ERCC2—breast cancer	2.02e-06	2.97e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NOS3—breast cancer	2e-06	2.96e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—MTHFR—breast cancer	1.89e-06	2.79e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.87e-06	2.75e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CB—breast cancer	1.85e-06	2.73e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTGS2—breast cancer	1.85e-06	2.73e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTGS2—breast cancer	1.83e-06	2.7e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CD—breast cancer	1.81e-06	2.67e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALB—breast cancer	1.79e-06	2.64e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CAV1—breast cancer	1.75e-06	2.58e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NOS3—breast cancer	1.71e-06	2.53e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—AKT1—breast cancer	1.66e-06	2.44e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CA—breast cancer	1.64e-06	2.41e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTEN—breast cancer	1.61e-06	2.38e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CA—breast cancer	1.6e-06	2.36e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTEN—breast cancer	1.6e-06	2.36e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CG—breast cancer	1.59e-06	2.35e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CB—breast cancer	1.58e-06	2.33e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTGS2—breast cancer	1.57e-06	2.31e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CD—breast cancer	1.4e-06	2.06e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALB—breast cancer	1.38e-06	2.04e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTEN—breast cancer	1.37e-06	2.01e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—AKT1—breast cancer	1.34e-06	1.97e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NOS3—breast cancer	1.32e-06	1.95e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—AKT1—breast cancer	1.31e-06	1.93e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CB—breast cancer	1.22e-06	1.8e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTGS2—breast cancer	1.21e-06	1.78e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CA—breast cancer	1.14e-06	1.68e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CA—breast cancer	1.13e-06	1.66e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTEN—breast cancer	1.05e-06	1.55e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CA—breast cancer	9.63e-07	1.42e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—AKT1—breast cancer	9.29e-07	1.37e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—AKT1—breast cancer	9.21e-07	1.36e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AKT1—breast cancer	7.87e-07	1.16e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CA—breast cancer	7.44e-07	1.1e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AKT1—breast cancer	6.07e-07	8.96e-06	CbGpPWpGaD
